Novonesis Plant Biosolutions A/S: Financial statements 2015
CVR: 30919246
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Novonesis Plant Biosolutions A/S (CVR 30919246) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 365,939,460 and a net result of DKK 83,747,531. Equity in the 2015 report amounted to DKK 1,433,245,261. The solvency ratio was 44.2%.
- Gross Profit
- DKK 365,939,460
- Profit/Loss
- DKK 83,747,531
- Equity
- DKK 1,433,245,261
- Total Assets
- DKK 3,243,277,201
Official annual report
How creditworthy is Novonesis Plant Biosolutions A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
Novonesis Plant Biosolutions A/S has published its annual report for 2014.
About Novonesis Plant Biosolutions A/S
Novonesis Plant Biosolutions A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2007. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The company was previously named NOVOZYMES BIOAG A/S and NOVOZYMES BIOLOGICALS HOLDING A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 126,088,828 and a net result of DKK 520,581,561 compared with DKK 403,926,577 the year before. Equity in the 2025 report amounted to DKK 853,779,346.
